ATE270329T1 - Verfahren zur bestimmung des gens eines zielproteins mit hilfe eines medikamentes - Google Patents
Verfahren zur bestimmung des gens eines zielproteins mit hilfe eines medikamentesInfo
- Publication number
- ATE270329T1 ATE270329T1 AT98914021T AT98914021T ATE270329T1 AT E270329 T1 ATE270329 T1 AT E270329T1 AT 98914021 T AT98914021 T AT 98914021T AT 98914021 T AT98914021 T AT 98914021T AT E270329 T1 ATE270329 T1 AT E270329T1
- Authority
- AT
- Austria
- Prior art keywords
- drug
- gene
- protein
- living organism
- administered
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 9
- 238000000034 method Methods 0.000 title abstract 6
- 229940079593 drug Drugs 0.000 title abstract 5
- 239000003814 drug Substances 0.000 title abstract 5
- 102000004169 proteins and genes Human genes 0.000 title abstract 4
- 239000000523 sample Substances 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- 239000004971 Cross linker Substances 0.000 abstract 1
- 238000003277 amino acid sequence analysis Methods 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 239000002299 complementary DNA Substances 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000001742 protein purification Methods 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1048—SELEX
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Computational Biology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP1998/001712 WO1999053094A1 (fr) | 1997-03-10 | 1998-04-15 | Procede de detection in vivo d'un gene proteique cible a l'aide de medicament |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE270329T1 true ATE270329T1 (de) | 2004-07-15 |
Family
ID=14208050
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98914021T ATE270329T1 (de) | 1998-04-15 | 1998-04-15 | Verfahren zur bestimmung des gens eines zielproteins mit hilfe eines medikamentes |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1072688B1 (de) |
| AT (1) | ATE270329T1 (de) |
| CA (1) | CA2328719A1 (de) |
| DE (1) | DE69824895T2 (de) |
| WO (1) | WO1999053094A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001259961A1 (en) * | 2000-05-08 | 2001-11-20 | Interuniversitair Micro-Elektronica Centrum | Method and technology for high-throughput lead profiling |
| WO2002087578A1 (fr) * | 2001-04-10 | 2002-11-07 | Nippon Shinyaku Co., Ltd. | Agent therapeutique pour rhumatisme articulaire chronique |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0754682T3 (da) * | 1994-04-06 | 2002-02-04 | Western Therapeutics Inst D | Aminostilbazolderivat og lægemiddel |
| WO1996031625A1 (en) * | 1995-04-07 | 1996-10-10 | Cytogen Corporation | Polypeptides having a functional domain of interest and methods of identifying and using same |
| ATE208828T1 (de) * | 1998-03-06 | 2001-11-15 | Novozymes As | Ein screeningverfahren, basierend auf fluoreszenzpolarisation |
-
1998
- 1998-04-15 CA CA002328719A patent/CA2328719A1/en not_active Abandoned
- 1998-04-15 EP EP98914021A patent/EP1072688B1/de not_active Expired - Lifetime
- 1998-04-15 WO PCT/JP1998/001712 patent/WO1999053094A1/ja not_active Ceased
- 1998-04-15 AT AT98914021T patent/ATE270329T1/de not_active IP Right Cessation
- 1998-04-15 DE DE69824895T patent/DE69824895T2/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999053094A1 (fr) | 1999-10-21 |
| DE69824895D1 (de) | 2004-08-05 |
| CA2328719A1 (en) | 1999-10-21 |
| EP1072688B1 (de) | 2004-06-30 |
| EP1072688A1 (de) | 2001-01-31 |
| DE69824895T2 (de) | 2005-06-30 |
| EP1072688A4 (de) | 2002-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN86102858A (zh) | 制备猪支原体的重组表面抗原及其疫苗的方法 | |
| DE60041355D1 (de) | Verfahren zur detektion von erkrankungen | |
| ATE438737T1 (de) | Verfahren für den nachweis von erkrankungen | |
| JPH04501260A (ja) | 分画化方法 | |
| DE59705683D1 (de) | IMMUNOLOGISCHES NACHWEISVERFAHREN VON ANTIKÖRPERN, DIE GEGEN GEWEBE-TRANSGLUTAMINASE (tTG) GERICHTET SIND, VERWENDUNG VON tTG ZUR DIAGNOSE UND THERAPIEKONTROLLE SOWIE ORALES PHARMAZEUTISCHES MITTEL ENTHALTEND tTG | |
| ATE470150T1 (de) | Methode zum schnellen identifizieren von kleinen organischen liganden | |
| DE60126592D1 (de) | Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs | |
| NO2010021I1 (no) | Denosumab | |
| EP2381259A4 (de) | Leberkrankheitsmarker, verfahren und vorrichtung zur messung davon sowie testverfahren für die pharmazeutische herstellung | |
| CN111239302B (zh) | 一种利用蛋白质内切酶切割胶原蛋白获得专属性肽段的方法和应用 | |
| RU2010101909A (ru) | Способ выявления или лечения реакции "трансплантат против хозяина" | |
| HUP0302240A2 (hu) | Humán receptorfehérjék, ezekkel kapcsolatos reagensek és eljárások | |
| Rani et al. | A review for the analysis of antidepressant, antiepileptic and quinolone type drugs in pharmaceuticals and environmental samples | |
| DE3876108D1 (de) | Diagnostischer test unter verwendung von nucleinsaeure-sonden. | |
| DK0771352T3 (da) | Ikke-typebestemmelig Haemophilus influenzae-LKP-spids-adhesinprotein og nukleinsyre | |
| ATE336003T1 (de) | Verfahren zur sepsisdiagnose durch bestimmung von anti-asialo-gangliosid-antikörpern | |
| ATE270329T1 (de) | Verfahren zur bestimmung des gens eines zielproteins mit hilfe eines medikamentes | |
| Zhang et al. | Rapid determination of free prolyl dipeptides and 4-hydroxyproline in urine using flow-gated capillary electrophoresis | |
| Iadarola et al. | Determination of amino acids by micellar EKC: recent advances in method development and novel applications to different matrices | |
| WO2003102579A3 (fr) | Methode de criblage de banques de molecules radioactives et ses applications | |
| EP3460070A1 (de) | Verbesserte detektion von antikoagulantien in körperfluids | |
| WO2006089219A3 (en) | Neoepitope detection of disease using protein arrays | |
| WO2007071829A3 (en) | Methods and means related to diseases | |
| Marini et al. | Increased [18F] DPA-714 Uptake in the Skeletal Muscle of SOD1G93A Mice: A New Potential of Translocator Protein 18 kDa Imaging in Amyotrophic Lateral Sclerosis | |
| Elessawy et al. | Determination of pregabalin in tissues and fluids by using GC |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |